Harborside Press

SHERPA: Unknown

People

  1. Hakimi
    Hakimi
  2. Ladanyi
    Ladanyi
  3. Chaft
    Chaft
  4. Chatila
    Chatila
  5. Kris
    Kris
  6. Kuo
    Kuo
  7. Levine
    Levine
  8. Lim
    Lim
  9. Reznik
    Reznik
  10. Riely
    Riely

Groups

  1. Human Oncology and Pathogenesis Program (7)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Solid Tumor Oncology Division (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)
  7. Center for Hematologic Malignancies (2)
  8. Center for Molecular Imaging and Biotechnology (2)
  9. Computational Oncology Service (2)
  10. Epidemiology and Biostatistics (2)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Guidelines (1)
  3. Meeting Abstract (1)
Groups
  1. Human Oncology and Pathogenesis Program (7)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Department of Pathology and Laboratory Medicine (4)
  5. Solid Tumor Oncology Division (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)

More Groups

People
  1. Abraham Hakimi (2)
  2. Marc Ladanyi (2)
  3. Agata Bielska (1)
  4. Andrew Zelenetz (1)
  5. Diane Reidy (1)
  6. Eduard Reznik (1)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2011 (2)
Publications
  1. Journal of the National Comprehensive Cancer Network (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The NF-I/a transcription factor is a HIF-independent oncogenic dependency in kidney cancer
    Meeting Abstract

    Scovell, J.; Zayas, S.; Grubb, T.; Kuo, F.; Reznik, E.; Hakimi, A. A.; Chakraborty, A.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: B-cell lymphomas, version 6.2023
    Guidelines

    Zelenetz, A. D.; Gordon, L. I.; Abramson, J. S.; Advani, R. H.; Andreadis, B.; Bartlett, N. L.; Budde, L. E.; Caimi, P. F.; Chang, J. E.; Christian, B.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Tumor mutational burden and mismatch repair deficiency discordance as a mechanism of immunotherapy resistance
    Journal Article

    Bielska, A. A.; Chatila, W. K.; Walch, H.; Schultz, N.; Stadler, Z. K.; Shia, J.; Reidy-Lagunes, D.; Yaeger, R.
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Whole-exome sequencing in two extreme phenotypes of response to VEGF-targeted therapies in patients with metastatic clear cell renal cell carcinoma
    Journal Article

    Fay, A. P.; de Velasco, G.; Ho, T. H.; Van Allen, E. M.; Murray, B.; Albiges, L.; Signoretti, S.; Hakimi, A. A.; Stanton, M. L.; Bellmunt, J.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms
    Journal Article

    Stein, B. L.; Gotlib, J.; Arcasoy, M.; Nguyen, M. H.; Shah, N.; Moliterno, A.; Jamieson, C.; Pollyea, D. A.; Scott, B.; Wadleigh, M.; more...
    Journal of the National Comprehensive Cancer Network (2015)

    Fulltext@MSK | Save
  • NCCN molecular testing white paper: Effectiveness, efficiency, and reimbursement
    Journal Article

    Engstrom, P. F.; Bloom, M. G.; Demetri, G. D.; Febbo, P. G.; Goeckeler, W.; Ladanyi, M.; Loy, B.; Murphy, K.; Nerenberg, M.; Papagni, P.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • Incorporation of crizotinib into the NCCN guidelines
    Journal Article

    Riely, G. J.; Chaft, J. E.; Ladanyi, M.; Kris, M. G.
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save